-
1
-
-
15944397361
-
Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels
-
Demiryu{double acute}rek A.T., and Demiryu{double acute}rek S. Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels. Auton Autacoid Pharmacol 25 (2005) 35-52
-
(2005)
Auton Autacoid Pharmacol
, vol.25
, pp. 35-52
-
-
Demiryurek, A.T.1
Demiryurek, S.2
-
2
-
-
0028844673
-
Effects of NO modulation on cardiac arrhythmias in the rat isolated heart
-
Pabla R., and Curtis M.J. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ Res 77 (1995) 984-992
-
(1995)
Circ Res
, vol.77
, pp. 984-992
-
-
Pabla, R.1
Curtis, M.J.2
-
3
-
-
0032946653
-
The role of nitric oxide in digoxin-induced arrhythmias in guinea-pigs
-
Altuǧ S., Uzun O., Demiryürek A.T., Cakici I., Abacioǧlu N., and Kanzik I. The role of nitric oxide in digoxin-induced arrhythmias in guinea-pigs. Pharmacol Toxicol 84 (1999) 3-8
-
(1999)
Pharmacol Toxicol
, vol.84
, pp. 3-8
-
-
Altuǧ, S.1
Uzun, O.2
Demiryürek, A.T.3
Cakici, I.4
Abacioǧlu, N.5
Kanzik, I.6
-
4
-
-
0030788304
-
The influence of a novel pentadecapeptide BPC 157 on NG-nitro-l-arginine methylester and l-arginine effect on stomach mucosal integrity and blood pressure
-
Sikiric P., Seiwerth S., Grabarevic Z., et al. The influence of a novel pentadecapeptide BPC 157 on NG-nitro-l-arginine methylester and l-arginine effect on stomach mucosal integrity and blood pressure. Eur J Pharmacol 332 (1997) 23-33
-
(1997)
Eur J Pharmacol
, vol.332
, pp. 23-33
-
-
Sikiric, P.1
Seiwerth, S.2
Grabarevic, Z.3
-
5
-
-
33751237599
-
Stable gastric pentadecapeptide BPC 157 studied for inflammatory bowel disease (PLD-116, PL14736, Pliva) induces nitric oxide synthesis
-
Turkovic B., Sikiric P., Seiwerth S., et al. Stable gastric pentadecapeptide BPC 157 studied for inflammatory bowel disease (PLD-116, PL14736, Pliva) induces nitric oxide synthesis. Gastroenterology 126 (2004) A287
-
(2004)
Gastroenterology
, vol.126
-
-
Turkovic, B.1
Sikiric, P.2
Seiwerth, S.3
-
6
-
-
3042835937
-
Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse
-
Lovric-Bencic M., Sikiric P., Hanzevacki J.S., et al. Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse. J Pharmacol Sci 95 (2004) 19-26
-
(2004)
J Pharmacol Sci
, vol.95
, pp. 19-26
-
-
Lovric-Bencic, M.1
Sikiric, P.2
Hanzevacki, J.S.3
-
7
-
-
0034898109
-
Crosstalk between endothelin and nitric oxide in the control of vascular tone
-
Lavallee M., Takamura M., Parent R., and Thorin E. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev 6 (2001) 265-276
-
(2001)
Heart Fail Rev
, vol.6
, pp. 265-276
-
-
Lavallee, M.1
Takamura, M.2
Parent, R.3
Thorin, E.4
-
8
-
-
10544235022
-
Arrhythmogenic action of endothelin peptides in isolated perfused whole hearts from guinea pigs and rats
-
Ercan Z.S., Ilhan M., Kilinc M., and Turker R.K. Arrhythmogenic action of endothelin peptides in isolated perfused whole hearts from guinea pigs and rats. Pharmacology 53 (1996) 234-240
-
(1996)
Pharmacology
, vol.53
, pp. 234-240
-
-
Ercan, Z.S.1
Ilhan, M.2
Kilinc, M.3
Turker, R.K.4
-
9
-
-
0026514515
-
Nitric oxide involvement in preconditioning of the ischaemic myocardium in anaesthetised dogs
-
Vegh A., Szekeres L., and Parratt J.R. Nitric oxide involvement in preconditioning of the ischaemic myocardium in anaesthetised dogs. J Physiol 446 (1992) 541P
-
(1992)
J Physiol
, vol.446
-
-
Vegh, A.1
Szekeres, L.2
Parratt, J.R.3
-
10
-
-
0000743581
-
Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart
-
Bosnjak Z.J., Graf B.M., Sikiric P., and Stowe D.F. Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart. FASEB J 8 (1994) A12
-
(1994)
FASEB J
, vol.8
-
-
Bosnjak, Z.J.1
Graf, B.M.2
Sikiric, P.3
Stowe, D.F.4
-
11
-
-
0027503914
-
A new gastric peptide BPC. An overview of stomach - organoprotection hypothesis and beneficial effect of BPC
-
(Paris)
-
Sikiric P., Petek M., Rucman R., et al. A new gastric peptide BPC. An overview of stomach - organoprotection hypothesis and beneficial effect of BPC. J Physiol 87 (1993) 313-327 (Paris)
-
(1993)
J Physiol
, vol.87
, pp. 313-327
-
-
Sikiric, P.1
Petek, M.2
Rucman, R.3
-
12
-
-
0028002278
-
The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesion induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promoters and gut peptides
-
Sikiric P., Seiwerth S., Grabarevic Z., et al. The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesion induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promoters and gut peptides. Life Sci 54 (1994) PL63-68
-
(1994)
Life Sci
, vol.54
-
-
Sikiric, P.1
Seiwerth, S.2
Grabarevic, Z.3
-
13
-
-
0033380855
-
The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation
-
(Paris)
-
Sikiric P., Separovic J., Anic T., et al. The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation. J Physiol 93 (1999) 479-485 (Paris)
-
(1999)
J Physiol
, vol.93
, pp. 479-485
-
-
Sikiric, P.1
Separovic, J.2
Anic, T.3
-
14
-
-
33845912425
-
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response
-
Sikiric P., Seiwerth S., Brcic L., et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response. Inflammopharmacology 14 (2006) 214-221
-
(2006)
Inflammopharmacology
, vol.14
, pp. 214-221
-
-
Sikiric, P.1
Seiwerth, S.2
Brcic, L.3
-
15
-
-
0030698091
-
The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks
-
(Paris)
-
Grabarevic Z., Tisljar M., Artukovic B., et al. The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks. J Physiol 91 (1997) 139-149 (Paris)
-
(1997)
J Physiol
, vol.91
, pp. 139-149
-
-
Grabarevic, Z.1
Tisljar, M.2
Artukovic, B.3
-
16
-
-
20244376315
-
Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats
-
Boban Blagaic A., Blagaic V., Mirt M., et al. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats. Eur J Pharmacol 512 (2005) 173-179
-
(2005)
Eur J Pharmacol
, vol.512
, pp. 173-179
-
-
Boban Blagaic, A.1
Blagaic, V.2
Mirt, M.3
-
17
-
-
30944442647
-
The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of NG-nitro-l-arginine methyl ester and l-arginine
-
Boban-Blagaic A., Blagaic V., Romic Z., et al. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of NG-nitro-l-arginine methyl ester and l-arginine. Med Sci Monit BR (2006) 36-45
-
(2006)
Med Sci Monit
, vol.BR
, pp. 36-45
-
-
Boban-Blagaic, A.1
Blagaic, V.2
Romic, Z.3
-
18
-
-
0000548565
-
Digestion of h-EGF, h-TGF alpha and BPC-15 in human gastric juice
-
Veljaca M., Chan K., and Guglietta A. Digestion of h-EGF, h-TGF alpha and BPC-15 in human gastric juice. Gastroenterology 108 (1995) A761
-
(1995)
Gastroenterology
, vol.108
-
-
Veljaca, M.1
Chan, K.2
Guglietta, A.3
-
19
-
-
0026720660
-
Nitric oxide mediates rat mucosal vasodilatation induced by intragastric capsaicin
-
Whittle B.J., Lopez-Belmonte J., and Moncada S. Nitric oxide mediates rat mucosal vasodilatation induced by intragastric capsaicin. Eur J Pharmacol 218 (1992) 339-341
-
(1992)
Eur J Pharmacol
, vol.218
, pp. 339-341
-
-
Whittle, B.J.1
Lopez-Belmonte, J.2
Moncada, S.3
-
20
-
-
0025883342
-
Nitric oxide: physiology, pathophysiology, and pharmacology
-
Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
-
(1991)
Pharmacol Rev
, vol.43
, pp. 109-142
-
-
Moncada, S.1
Palmer, R.M.2
Higgs, E.A.3
-
21
-
-
0027396551
-
The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa
-
Lopez-Belmonte J., Whittle B.J., and Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 108 (1993) 73-78
-
(1993)
Br J Pharmacol
, vol.108
, pp. 73-78
-
-
Lopez-Belmonte, J.1
Whittle, B.J.2
Moncada, S.3
-
22
-
-
0032521182
-
Involvement of nitric oxide system in experimental muscle crush injury
-
Rubinstein I., Abassi Z., Coleman R., Milman F., Winaver J., and Better O.S. Involvement of nitric oxide system in experimental muscle crush injury. J Clin Invest 101 (1998) 1325-1333
-
(1998)
J Clin Invest
, vol.101
, pp. 1325-1333
-
-
Rubinstein, I.1
Abassi, Z.2
Coleman, R.3
Milman, F.4
Winaver, J.5
Better, O.S.6
-
23
-
-
34249037141
-
Ulcerative Colitis Study Group. A multicenter, randomized, double blind, placebo-controlled phase II study of PL 14736 enema in the treatment of mild-to-moderate ulcerative colitis
-
Ruenzi M., Stolte M., Veljaca M., Oreskovic K., and Peterson J. Ulcerative Colitis Study Group. A multicenter, randomized, double blind, placebo-controlled phase II study of PL 14736 enema in the treatment of mild-to-moderate ulcerative colitis. Gastroenterology 128 (2005) A584
-
(2005)
Gastroenterology
, vol.128
-
-
Ruenzi, M.1
Stolte, M.2
Veljaca, M.3
Oreskovic, K.4
Peterson, J.5
-
24
-
-
33845900761
-
Safety, tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers
-
Veljaca M., Pavic Sladoljev D., Mildner B., et al. Safety, tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers. Gut 51 (2003) A309
-
(2003)
Gut
, vol.51
-
-
Veljaca, M.1
Pavic Sladoljev, D.2
Mildner, B.3
|